⚡ Flash Summary

Ferozsons Laboratories Limited will host a virtual Corporate Briefing Session on November 21, 2025, at 11:00 a.m. to discuss the company’s financial performance. The session will cover the year ended June 30, 2025, and the first quarter ended September 30, 2025. Shareholders, investors, and analysts are invited to participate via Zoom. Meeting credentials, including the meeting link and ID, are provided in the announcement.

📌 Key Takeaways

• 🗓️ Corporate Briefing Session scheduled for November 21, 2025.
• 💻 Session will be held virtually via Zoom.
• ⏰ Meeting starts at 11:00 a.m. local time.
• 🗣️ Intended for shareholders, investors, and analysts.
• 📊 Discussion will cover financial performance for the year ended June 30, 2025.
• Q1 Financial performance for the quarter ended September 30, 2025 will be discussed.
• 🔗 Meeting Link: https://us02web.zoom.us/j/86556425413
• 🆔 Meeting ID: 865 5642 5413
• 🤝 Encourages attendees to join with their name and institution.
• 🔇 Recommends attendees to stay on mute during the presentation.
• 💬 Suggests typing questions in the chat box.
• ✉️ Contact email: info@ferozsons-labs.com
• 🌐 Website: www.ferozsons-labs.com
• 🏢 Registered office is located in Rawalpindi.
• 🏭 Pharma factory located in Nowshera.

🎯 Investment Thesis

HOLD. Without specific financial data, it’s difficult to determine a BUY or SELL recommendation. The corporate briefing session will provide crucial information to refine an investment thesis. A HOLD recommendation is appropriate until further information is released during the session.